Continuation rates with a levonorgestrel-releasing contraceptive implant. Prospective study in Belgium;Continuite d'utilisation d'un implant contraceptif au levonorgestrel: Etude prospective en Belgique

Revue Medicale de Bruxelles

Volumn 17, Issue 6, 1996, Pages 375-381

  Vekemans, M ^a   Delvigne, A ^a   Paesmans, M ^b  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE;

AGE; ARTICLE; DRUG EFFICACY; DRUG IMPLANT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY RATE; SUBCUTANEOUS DRUG ADMINISTRATION; ADULT; COHORT ANALYSIS; PARITY; PREGNANCY; PROSPECTIVE STUDY; TIME;

ADULT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HUMANS; LEVONORGESTREL; PARITY; PREGNANCY; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0030341512     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. McIntosh N, Riseborough P, Davis C : Norplant®, Guide Pratique à l'intention des programmes de Planification Familiale. Baltimore, JHPIEGO, 1993, p 5
2. Aguillaume CJ, Sivin I, Bardin CW : Les implants Norplant® : la première génération de contraceptifs sous-cutanés féminins Réfé rences en Gynécologie Obstétrique 2 : 268-280, 1994
3. Vekemans M : Les implants sous-dermiques. In Pratique et gestion de la planification familiale dans les pays en voie de développement à l'usage des cliniciens, des formateurs, des gestionnaires, édité par Wollast E, Vekemans M, Bruxelles, De Boeck-Wesmael, 1993, pp 241-245
4. Vekemans M, Tissot B : Contraception par un implant sous-cutané, le Norplant®. Rev Méd Brux 13 : 292-298, 1992
5. Matthews DE, Farewell VT . The Log-Rank or Mantel Haenszel test for the Comparison of Survival Curves. In Using and understanding medical statistics, Basel, Karger, 1988, pp 79-87
6. Sivin I, Robertson DN, Stern J, Croxatto HB, Diaz S, Coutinho E, da Silva AR, Alvarez Sanchez F, Faundes A, McDonald O, Holma P, Nielsen NC, Osler M, Nash HA : Norplant® : Reversible implant contraception. Studies in Family Planning 11 : 227-235, 1980
7. Affandi B, Santoso SSI, Djajadilaga HW, Moeloek FA, Primartono J, Lubis F, Samil RS : Five-year experience with Norplant®. Contraception 36 : 417-128, 1987
8. Koetsawang S, Varakamain S, Satayapan S, Dusitsin N : Norplant® clinical study in Thailand- In Long-acting contraceptive delivery systems, edited by Zatuchni GI, Goldsmith A, Shelton JD, Sciarra JJ, Philadelphia, Harper and Row, 1984, pp 459-470
9. Me Caulay AP, Geller JS : Decisions for Norplant® Programs. Population Reports, Series K, N°4, 1992
10. Sakh M, Ahmed A-G, Abo-Eloyoun M, Shaaban MM : Five-year experience with Norplant® implants in Assiut, Egypt. Contraception 35 : 543-550, 1987
11. Satayapan S, Kanchanasinith K, Varakamin S : Perceptions and acceptability of Norplant® implants in Thailand. Studies in Family Planning 14 : 170-176, 1983
12. Sivin I : International experience with Norplant® and Norplant® II contraceptives. Studies in Family Planning 19 : 81-94, 1988
13. Marangoni P, Cartagena S, Alvarado J, Diaz J, Faundes A : Norplant® implants and the T Cu 200 IUD : a comparative study in Ecuador. Studies in Family Planning 14 : 177-180, 1983
14. Sarma SP, Hatcher RP : Neurovascular injury during removal of levonorgestrel implants. Am J Obstet Gynecol 172 : 120-121, 1995
15. Sivin I, El Maghoub S, McCarthy T : Long-term contraception with the levonorgestrel 20 mg :day (LNg 20) and the Copper T 380 Ag intrauterine devices : A five-year randomized study. Contraception 42 : 361-378, 1990
16. Trussell J, Hatcher RA, Cates W Jr, Stewart FH, Kost K : Contraceptive failure in the United States : An update. Studies in Family Planning 22 : 51-54, 1990
17. Edelman DA : Development and testing of vaginal contraceptives : final report. Family Health International, Research Triangle Park, North Carolina, 1983